Category Archives: Product Review

GW Pharmaceuticals (Nasdaq: GWPH), a UK based biopharmaceutical company, has announced impressive new FDA clinical trial results for its cannabis (marijuana) based drug, Epidiolex. Epidiolex is being studied as a potential treatment for rare forms of childhood epilepsy, namely Dravet and Lennox-Gastaut syndrome (LGS). The drug could represent a life-line to children suffering from this … Continue reading →